NCT00214253View on ClinicalTrials.gov

Islet Transplantation in Type 1 Diabetic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Type 1 Diabetes
Interventions
DRUG

Thiazolidinedione

Thiazolidinedione vs. no intervention with standard immunosuppression using Edmonton Protocol

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00214253 - Islet Transplantation in Type 1 Diabetic Patients | Biotech Hunter | Biotech Hunter